Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program

J Am Coll Nutr. 2001 Aug;20(4):293-306. doi: 10.1080/07315724.2001.10719050.

Abstract

Objective: To investigate the effect of chromium picolinate (CP) supplementation on body composition, resting metabolic rate (RMR), selected biochemical parameters and iron and zinc status in moderately obese women participating in a 12-week exercise program.

Methods: Forty-four women, 27 to 51 years of age, were randomly assigned to two groups based on their body mass index. Subjects received either 400 microg/day of chromium as a CP supplement or a placebo in double-blind fashion and participated in a supervised weight-training and walking program two days per week for 12 weeks. Body composition and RMR were measured at baseline, 6 and 12 weeks. Selected biochemical parameters and iron and zinc status were measured at baseline and 12 weeks.

Results: Body composition and RMR were not significantly changed by CP supplementation. No significant differences in fasting plasma glucose, serum insulin, plasma glucagon, serum C-peptide and serum lipid concentrations or in iron and zinc indices were found between the two groups over time. Serum total cholesterol concentration significantly decreased (p = 0.0016) over time for all subjects combined, probably as a result of the exercise training. Exercise training significantly reduced total iron binding capacity (TIBC) by 3% for all subjects combined (p = 0.001 1).

Conclusions: Twelve weeks of 400 microg/day of chromium as a CP supplement did not significantly affect body composition, RMR, plasma glucose, serum insulin, plasma glucagon, serum C-peptide and serum lipid concentrations or iron and zinc indices in moderately obese women placed on an exercise program. The changes in serum total cholesterol levels and TIBC were a result of the exercise program.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Basal Metabolism*
  • Blood Glucose / analysis
  • Blood Proteins / metabolism
  • Body Composition*
  • C-Peptide / blood
  • Cholesterol / blood
  • Chromium / administration & dosage*
  • Chromium / blood
  • Chromium / urine
  • Diet
  • Dietary Supplements
  • Double-Blind Method
  • Exercise*
  • Fasting
  • Female
  • Glucagon / blood
  • Humans
  • Insulin / blood
  • Iron / blood
  • Iron / urine
  • Lipids / blood
  • Middle Aged
  • Obesity / therapy*
  • Patient Compliance
  • Placebos
  • Zinc / blood

Substances

  • Blood Glucose
  • Blood Proteins
  • C-Peptide
  • Insulin
  • Lipids
  • Placebos
  • Chromium
  • Glucagon
  • Cholesterol
  • Iron
  • Zinc